Exact Mass: 345.1787

Exact Mass Matches: 345.1787

Found 111 metabolites which its exact mass value is equals to given mass value 345.1787, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

Murrayacinine

3,11-Dihydro-3-methyl-3-(4-methyl-3-pentenyl)pyrano[3,2-a]carbazole-5-carboxaldehyde, 9ci

C23H23NO2 (345.1729)


Murrayacinine is found in herbs and spices. Murrayacinine is an alkaloid from the stem bark of Murraya koenigii (curryleaf tree

   

Cyclofoxy

4-(cyclopropylmethyl)-14-fluoro-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,17-diol

C20H24FNO3 (345.174)


   

4-[[4-Amino-6-(2,4,6-trimethylanilino)-1,3,5-triazin-2-yl]amino]benzonitrile

4-({4-amino-6-[(2,4,6-trimethylphenyl)amino]-1,3,5-triazin-2-yl}amino)benzonitrile

C19H19N7 (345.1702)


   

Crisnatol

2-{[(chrysen-6-yl)methyl]amino}-2-methylpropane-1,3-diol

C23H23NO2 (345.1729)


   

L-Arginine, L-asparaginylglycyl-

2-[(2-{[2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-1-hydroxyethylidene)amino]-5-carbamimidamidopentanoate

C12H23N7O5 (345.1761)


   

4-Tert-butyl-2-[(tert-butylamino)methyl]-6-(4-chlorophenyl)phenol

5-tert-butyl-3-[(tert-butylamino)methyl]-4-chloro-[1,1-biphenyl]-2-ol

C21H28ClNO (345.1859)


   

Murrayamine M

Murrayamine M

C23H23NO2 (345.1729)


   

Murrayamine J

Murrayamine J

C23H23NO2 (345.1729)


   

EUROPINE N-OXIDE

EUROPINE N-OXIDE

C16H27NO7 (345.1787)


   

(1-(3-chloropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

(1-(3-chloropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

C21H28ClNO (345.1859)


   

(1-(4-chloropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

(1-(4-chloropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

C21H28ClNO (345.1859)


   

UR-144 N-(5-chloropentyl) analog

UR-144 N-(5-chloropentyl) analog

C21H28ClNO (345.1859)


   

(1-(2-chloropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

(1-(2-chloropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

C21H28ClNO (345.1859)


   

alpha-N-acetyl-indole-3-acetyl-epsilon-L-lysine|N-alpha-Acetyl-N-epsilon-(indole-3-acetyl)-L-lysine

alpha-N-acetyl-indole-3-acetyl-epsilon-L-lysine|N-alpha-Acetyl-N-epsilon-(indole-3-acetyl)-L-lysine

C18H23N3O4 (345.1688)


   

Clausenawalline C

Clausenawalline C

C23H23NO2 (345.1729)


   
   
   
   
   
   
   

glycylasparagylarginine

glycylasparagylarginine

C12H23N7O5 (345.1761)


   
   

Gly Gly Gly Arg

(2S)-2-{2-[2-(2-aminoacetamido)acetamido]acetamido}-5-carbamimidamidopentanoic acid

C12H23N7O5 (345.1761)


   

Gly Gly Arg Gly

2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-5-carbamimidamidopentanamido]acetic acid

C12H23N7O5 (345.1761)


   

Gly Arg Gly Gly

2-{2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]acetamido}acetic acid

C12H23N7O5 (345.1761)


   
   
   
   
   
   
   
   
   
   

Arg Gly Gly Gly

2-(2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}acetamido)acetic acid

C12H23N7O5 (345.1761)


   
   

PF-750

N-phenyl-4-(quinolin-2-ylmethyl)piperidine-1-carboxamide

C22H23N3O (345.1841)


PF 750 is a selective and covalent fatty acid amide hydrolase (FAAH) inhibitor, with IC50s varied from 16.2-595 nM in different pre-incubation times. Covalently modifies the enzyme’s active site serine nucleophile[1].

   

Murrayacinine

5-methyl-5-(4-methylpent-3-en-1-yl)-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaene-8-carbaldehyde

C23H23NO2 (345.1729)


   

(+/-)-PPHT HYDROCHLORIDE (N-0434) POTENT D2 DOPAMINE RE

(+/-)-PPHT HYDROCHLORIDE (N-0434) POTENT D2 DOPAMINE RE

C21H28ClNO (345.1859)


   

(3-BENZYLOXY-BENZYL)-HYDRAZINE

(3-BENZYLOXY-BENZYL)-HYDRAZINE

C18H23N3O4 (345.1688)


   

BOC-HIS(BZL)-OH

BOC-HIS(BZL)-OH

C18H23N3O4 (345.1688)


   

4-[4-(2-phenylethyl)piperidin-1-yl]quinazoline-6-carbaldehyde

4-[4-(2-phenylethyl)piperidin-1-yl]quinazoline-6-carbaldehyde

C22H23N3O (345.1841)


   

METHYL(2S)-2-(BIS(TERT-BUTOXYCARBONYL)AMINO)-5-OXOPENTANOATE

METHYL(2S)-2-(BIS(TERT-BUTOXYCARBONYL)AMINO)-5-OXOPENTANOATE

C16H27NO7 (345.1787)


   

(2R,3S)-1-CHLORO-3-DIBENZYLAMINO-5-METHYLHEXAN-2-OL

(2R,3S)-1-CHLORO-3-DIBENZYLAMINO-5-METHYLHEXAN-2-OL

C21H28ClNO (345.1859)


   

1-Benzyl-N-(tert-butoxycarbonyl)-D-histidine

1-Benzyl-N-(tert-butoxycarbonyl)-D-histidine

C18H23N3O4 (345.1688)


   

TERT-BUTYL 4-(2-CARBAMOYLBENZOFURAN-5-YL)PIPERAZINE-1-CARBOXYLATE

TERT-BUTYL 4-(2-CARBAMOYLBENZOFURAN-5-YL)PIPERAZINE-1-CARBOXYLATE

C18H23N3O4 (345.1688)


   

2-(4-Boc-piperazinyl)-α-(2-cyano-phenyl)acetic acid

2-(4-Boc-piperazinyl)-α-(2-cyano-phenyl)acetic acid

C18H23N3O4 (345.1688)


   

Diphenidol hydrochloride

Diphenidol (hydrochloride)

C21H28ClNO (345.1859)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Diphenidol hydrochloride (Difenidol hydrochloride) is a non-selective muscarinic M1-M4 receptor antagonist, has anti-arrhythmic activity. Diphenidol hydrochloride is also a potent non-specific blocker of voltage-gated ion channels (Na+, K+, and Ca2+) in neuronal cells. Diphenidol hydrochloride can be used in the study of antivertigo and antinausea[1][2][3][4][5].

   

Dibenzyl diisopropylphosphoramidoite

Dibenzyl diisopropylphosphoramidoite

C20H28NO2P (345.1858)


   

2-ISOBUTOXY-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-5-(TRIFLUOROMETHYL)PYRIDINE

2-ISOBUTOXY-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-5-(TRIFLUOROMETHYL)PYRIDINE

C16H23BF3NO3 (345.1723)


   

2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)-2-(3-cyanophenyl)a

2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)-2-(3-cyanophenyl)a

C18H23N3O4 (345.1688)


   

2-(4-BOC-PIPERAZINYL)-2-(4-CYANO-PHENYL)ACETIC ACID

2-(4-BOC-PIPERAZINYL)-2-(4-CYANO-PHENYL)ACETIC ACID

C18H23N3O4 (345.1688)


   
   

methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate

methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate

C17H23N5O3 (345.1801)


   

Levomethadone hydrochloride

(6R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone hydrochloride (1: 1)

C21H28ClNO (345.1859)


   

Methadone hydrochloride

Methadone hydrochloride

C21H28ClNO (345.1859)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Metipranolol Hydrochloride

Metipranolol Hydrochloride

C17H28ClNO4 (345.1707)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist Metipranolol hydrochloride is a non-selective β adrenergic receptor blocking agent.

   

Crisnatol

Crisnatol

C23H23NO2 (345.1729)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

4-Tert-butyl-2-[(tert-butylamino)methyl]-6-(4-chlorophenyl)phenol

4-Tert-butyl-2-[(tert-butylamino)methyl]-6-(4-chlorophenyl)phenol

C21H28ClNO (345.1859)


   

N-(1-naphthalenyl)-4-(phenylmethyl)-1-piperazinecarboxamide

N-(1-naphthalenyl)-4-(phenylmethyl)-1-piperazinecarboxamide

C22H23N3O (345.1841)


   

Ethyl 2-[4-(carbamoylamino)-8-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetate

Ethyl 2-[4-(carbamoylamino)-8-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetate

C18H23N3O4 (345.1688)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   
   

L-Arginine, L-asparaginylglycyl-

2-[(2-{[2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-1-hydroxyethylidene)amino]-5-carbamimidamidopentanoate

C12H23N7O5 (345.1761)


   

GA44 free alcohol form

GA44 free alcohol form

C20H25O5- (345.1702)


   
   

GA37 (closed lactone form)

GA37 (closed lactone form)

C20H25O5- (345.1702)


   

N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide

N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide

C22H23N3O (345.1841)


PF 750 is a selective and covalent fatty acid amide hydrolase (FAAH) inhibitor, with IC50s varied from 16.2-595 nM in different pre-incubation times. Covalently modifies the enzyme’s active site serine nucleophile[1].

   

(R)-Pefurazoate

(R)-Pefurazoate

C18H23N3O4 (345.1688)


   
   

gibberellin A44(1-)

gibberellin A44(1-)

C20H25O5- (345.1702)


Conjugate base of gibberellin A44.

   

(S)-pefurazoate

(S)-pefurazoate

C18H23N3O4 (345.1688)


   

Arginyl-glycyl-asparagine

Arginyl-glycyl-asparagine

C12H23N7O5 (345.1761)


   

3-[[2-(4-Methyl-1-piperazinyl)-1-oxoethyl]amino]-2-benzofurancarboxylic acid ethyl ester

3-[[2-(4-Methyl-1-piperazinyl)-1-oxoethyl]amino]-2-benzofurancarboxylic acid ethyl ester

C18H23N3O4 (345.1688)


   

4-[[(4S)-2-amino-3-[2-(1-naphthalenyl)ethyl]-4,5-dihydroimidazol-4-yl]methyl]phenol

4-[[(4S)-2-amino-3-[2-(1-naphthalenyl)ethyl]-4,5-dihydroimidazol-4-yl]methyl]phenol

C22H23N3O (345.1841)


   

(S,S)-formoterol(1+)

(S,S)-formoterol(1+)

C19H25N2O4+ (345.1814)


   
   

3-[4-(acetyloxy)-2,3,5-trimethylphenoxy]-2-hydroxy-N-(propan-2-yl)propan-1-aminium chloride

3-[4-(acetyloxy)-2,3,5-trimethylphenoxy]-2-hydroxy-N-(propan-2-yl)propan-1-aminium chloride

C17H28ClNO4 (345.1707)


   

N-[(2S,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

N-[(2S,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

C18H23N3O4 (345.1688)


   

4-[[(1S,5R)-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]oxazole

4-[[(1S,5R)-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]oxazole

C22H23N3O (345.1841)


   

N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]pyridine-4-carboxamide

N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]pyridine-4-carboxamide

C18H23N3O4 (345.1688)


   

N-[(2R,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

N-[(2R,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

C18H23N3O4 (345.1688)


   

N-[(2S,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

N-[(2S,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

C18H23N3O4 (345.1688)


   

N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

C18H23N3O4 (345.1688)


   

N-[(2R,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

N-[(2R,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

C18H23N3O4 (345.1688)


   

N-[(2R,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

N-[(2R,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

C18H23N3O4 (345.1688)


   

N-[(2R,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

N-[(2R,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-pyridinecarboxamide

C18H23N3O4 (345.1688)


   
   
   
   
   
   
   
   
   
   
   

TCS 46b

TCS 46b

C22H23N3O (345.1841)


TCS 46b (Compound 46b) is a potent, selective and orally active NMDA NR1A/2B receptor antagonist with an IC50 of 5.3 nM[1]. TCS 46b is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

16,20,20-trimethyl-15-oxa-4-azahexacyclo[14.4.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁹,²¹]henicosa-2(14),3(11),5(10),6,8,12-hexaene-8-carbaldehyde

16,20,20-trimethyl-15-oxa-4-azahexacyclo[14.4.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁹,²¹]henicosa-2(14),3(11),5(10),6,8,12-hexaene-8-carbaldehyde

C23H23NO2 (345.1729)


   

3-methyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole-8-carbaldehyde

3-methyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole-8-carbaldehyde

C23H23NO2 (345.1729)


   

(3r)-3-methyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole-8-carbaldehyde

(3r)-3-methyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole-8-carbaldehyde

C23H23NO2 (345.1729)


   

(3s)-3-methyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole-8-carbaldehyde

(3s)-3-methyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole-8-carbaldehyde

C23H23NO2 (345.1729)


   

7-chloro-3-(7-hydroxy-2-methylhepta-2,4-dien-1-yl)-1-methyl-hexahydro-2h-indolizine-1,2,8-triol

7-chloro-3-(7-hydroxy-2-methylhepta-2,4-dien-1-yl)-1-methyl-hexahydro-2h-indolizine-1,2,8-triol

C17H28ClNO4 (345.1707)


   

(1s,2s,3s,7s,8s,8ar)-7-chloro-3-[(2z,4e)-7-hydroxy-2-methylhepta-2,4-dien-1-yl]-1-methyl-hexahydro-2h-indolizine-1,2,8-triol

(1s,2s,3s,7s,8s,8ar)-7-chloro-3-[(2z,4e)-7-hydroxy-2-methylhepta-2,4-dien-1-yl]-1-methyl-hexahydro-2h-indolizine-1,2,8-triol

C17H28ClNO4 (345.1707)


   

(1r,16r,19s,21r)-16,20,20-trimethyl-15-oxa-4-azahexacyclo[14.4.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁹,²¹]henicosa-2(14),3(11),5(10),6,8,12-hexaene-8-carbaldehyde

(1r,16r,19s,21r)-16,20,20-trimethyl-15-oxa-4-azahexacyclo[14.4.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁹,²¹]henicosa-2(14),3(11),5(10),6,8,12-hexaene-8-carbaldehyde

C23H23NO2 (345.1729)


   

(1s,2s,3s,7s,8s,8ar)-7-chloro-3-[(2e,4e)-7-hydroxy-2-methylhepta-2,4-dien-1-yl]-1-methyl-hexahydro-2h-indolizine-1,2,8-triol

(1s,2s,3s,7s,8s,8ar)-7-chloro-3-[(2e,4e)-7-hydroxy-2-methylhepta-2,4-dien-1-yl]-1-methyl-hexahydro-2h-indolizine-1,2,8-triol

C17H28ClNO4 (345.1707)


   

(7s,7ar)-1-({[(2r)-2,3-dihydroxy-2-[(1s)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

(7s,7ar)-1-({[(2r)-2,3-dihydroxy-2-[(1s)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

C16H27NO7 (345.1787)


   

6-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}-2-[(1-hydroxyethylidene)amino]hexanoic acid

6-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}-2-[(1-hydroxyethylidene)amino]hexanoic acid

C18H23N3O4 (345.1688)


   

(2s)-6-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}-2-[(1-hydroxyethylidene)amino]hexanoic acid

(2s)-6-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}-2-[(1-hydroxyethylidene)amino]hexanoic acid

C18H23N3O4 (345.1688)


   

(1s,16s,19r,21s)-16,20,20-trimethyl-15-oxa-4-azahexacyclo[14.4.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁹,²¹]henicosa-2(14),3(11),5(10),6,8,12-hexaene-8-carbaldehyde

(1s,16s,19r,21s)-16,20,20-trimethyl-15-oxa-4-azahexacyclo[14.4.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁹,²¹]henicosa-2(14),3(11),5(10),6,8,12-hexaene-8-carbaldehyde

C23H23NO2 (345.1729)